Semaglutide Helps Prevent Kidney Damage in People with Obesity
A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.
Health News is provided as a service to Reeves Drug Store site users by HealthDay. Reeves Drug Store nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.